Patent Assignment
Reel/Frame 052383/0705
Release of Security Interest
Recorded: 2020-04-13
Pages: 11
Assignor
BIOPHARMA CREDIT PLC
Executed: 2019-04-24
Assignee
NOVOCURE LIMITED
SECOND FLOOR, NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, JE2 4UF, JERSEY
Covered Properties
(41)
Method and Apparatus for Destroying Dividing Cells
Apparatus for Destroying Dividing Cells
Apparatus and Method for Treating a Tumor or the Like
Method and Apparatus for Destroying Dividing Cells
Apparatus for Treating a Tumor or the Like and Articles Incorporating the Apparatus for Treatment of the Tumor
Apparatus and Method for Optimizing Tumor Treatment Efficiency by Electric Fields
Treating a Tumor or the Like with an Electric Field That Is Focused at a Target Region
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating a Tumor or the Like with Electric Fields at Different Orientations
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Treating a Tumor or the Like with Electric Fields at Different Orientations
Apparatus and Method for Preventing the Spread of Cancerous Metastases and for Elimination of Metastases
Hat for Treating a Tumor or the Like
Probe for Treating a Tumor or the Like
Article of Clothing for Treating a Tumor or the Like
Apparatus for Selectively Destroying Dividing Cells
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Composite Electrode
Tissue Liquefaction and Aspiration
Patent:
43,617 →
Application:
12/030,694 →
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Bacteria with Electric Fields
Treating Parasites with Electric Fields
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Probe for Treating a Tumor or the Like
Treating Bacteria with Electric Fields
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Composite Electrode
Optimizing Treatment Using Ttfields by Changing the Frequency During the Course of Long Term Tumor Treatment
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
High Voltage, High Efficiency Sine Wave Generator with Pre-Set Frequency and Adjustable Amplitude
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jul 11, 2012
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 028527/0432 →
Release of Security Interest
Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
Assignment of Assignor's Interest
Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
Change of Name
Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
Security Interest
Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
Release of Security Interest
Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
Security Interest
May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
Assignment of Assignor's Interest
Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 045278/0825
Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
Omnibus Confirmation of Assignment Agreement
May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 50395/0398
Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 45278 0825
Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
Security Interest
Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
Release of Security Interest
Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement
May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →